782 related articles for article (PubMed ID: 30888065)
1. Role of SCFAs in gut microbiome and glycolysis for colorectal cancer therapy.
Wang G; Yu Y; Wang YZ; Wang JJ; Guan R; Sun Y; Shi F; Gao J; Fu XL
J Cell Physiol; 2019 Aug; 234(10):17023-17049. PubMed ID: 30888065
[TBL] [Abstract][Full Text] [Related]
2. The Role of Diet Related Short-Chain Fatty Acids in Colorectal Cancer Metabolism and Survival: Prevention and Therapeutic Implications.
Gomes SD; Oliveira CS; Azevedo-Silva J; Casanova MR; Barreto J; Pereira H; Chaves SR; Rodrigues LR; Casal M; Côrte-Real M; Baltazar F; Preto A
Curr Med Chem; 2020; 27(24):4087-4108. PubMed ID: 29848266
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the Tumor Microenvironment by Microbiota-Derived Short-Chain Fatty Acids: Impact in Colorectal Cancer Therapy.
Gomes S; Rodrigues AC; Pazienza V; Preto A
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982144
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota-derived short-chain fatty acids and colorectal cancer: Ready for clinical translation?
Hou H; Chen D; Zhang K; Zhang W; Liu T; Wang S; Dai X; Wang B; Zhong W; Cao H
Cancer Lett; 2022 Feb; 526():225-235. PubMed ID: 34843863
[TBL] [Abstract][Full Text] [Related]
5. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.
Zhang SL; Mao YQ; Zhang ZY; Li ZM; Kong CY; Chen HL; Cai PR; Han B; Ye T; Wang LS
Theranostics; 2021; 11(9):4155-4170. PubMed ID: 33754054
[No Abstract] [Full Text] [Related]
6. Evaluation and comparison of short chain fatty acids composition in gut diseases.
Niccolai E; Baldi S; Ricci F; Russo E; Nannini G; Menicatti M; Poli G; Taddei A; Bartolucci G; Calabrò AS; Stingo FC; Amedei A
World J Gastroenterol; 2019 Sep; 25(36):5543-5558. PubMed ID: 31576099
[TBL] [Abstract][Full Text] [Related]
7. Anticancer Effects of Gut Microbiota-Derived Short-Chain Fatty Acids in Cancers.
Son MY; Cho HS
J Microbiol Biotechnol; 2023 Jul; 33(7):849-856. PubMed ID: 37100764
[TBL] [Abstract][Full Text] [Related]
8. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.
van de Wouw M; Boehme M; Lyte JM; Wiley N; Strain C; O'Sullivan O; Clarke G; Stanton C; Dinan TG; Cryan JF
J Physiol; 2018 Oct; 596(20):4923-4944. PubMed ID: 30066368
[TBL] [Abstract][Full Text] [Related]
9. Echinacoside inhibits colorectal cancer metastasis via modulating the gut microbiota and suppressing the PI3K/AKT signaling pathway.
Wei J; Zheng Z; Hou X; Jia F; Yuan Y; Yuan F; He F; Hu L; Zhao L
J Ethnopharmacol; 2024 Jan; 318(Pt A):116866. PubMed ID: 37429503
[TBL] [Abstract][Full Text] [Related]
10. Correlation between microbes and colorectal cancer: tumor apoptosis is induced by sitosterols through promoting gut microbiota to produce short-chain fatty acids.
Ma H; Yu Y; Wang M; Li Z; Xu H; Tian C; Zhang J; Ye X; Li X
Apoptosis; 2019 Feb; 24(1-2):168-183. PubMed ID: 30506375
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of the "food-microorganism-SCFAs" axis on colorectal cancer: from basic research to practical application.
Shuwen H; Miao D; Quan Q; Wei W; Zhongshan Z; Chun Z; Xi Y
J Cancer Res Clin Oncol; 2019 Sep; 145(9):2169-2197. PubMed ID: 31401674
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs).
Ratajczak W; Rył A; Mizerski A; Walczakiewicz K; Sipak O; Laszczyńska M
Acta Biochim Pol; 2019 Mar; 66(1):1-12. PubMed ID: 30831575
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota-derived short-chain fatty acids and kidney diseases.
Li L; Ma L; Fu P
Drug Des Devel Ther; 2017; 11():3531-3542. PubMed ID: 29270002
[TBL] [Abstract][Full Text] [Related]
14. Higher Fecal Short-Chain Fatty Acid Levels Are Associated with Gut Microbiome Dysbiosis, Obesity, Hypertension and Cardiometabolic Disease Risk Factors.
de la Cuesta-Zuluaga J; Mueller NT; Álvarez-Quintero R; Velásquez-Mejía EP; Sierra JA; Corrales-Agudelo V; Carmona JA; Abad JM; Escobar JS
Nutrients; 2018 Dec; 11(1):. PubMed ID: 30591685
[TBL] [Abstract][Full Text] [Related]
15. Short chain fatty acids prime colorectal cancer cells to activate antitumor immunity.
Mowat C; Dhatt J; Bhatti I; Hamie A; Baker K
Front Immunol; 2023; 14():1190810. PubMed ID: 37304266
[TBL] [Abstract][Full Text] [Related]
16. The impact of microbiota-derived short-chain fatty acids on macrophage activities in disease: Mechanisms and therapeutic potentials.
Duan H; Wang L; Huangfu M; Li H
Biomed Pharmacother; 2023 Sep; 165():115276. PubMed ID: 37542852
[TBL] [Abstract][Full Text] [Related]
17. Effects of short chain fatty acids on metabolic and inflammatory processes in human health.
Campos-Perez W; Martinez-Lopez E
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 May; 1866(5):158900. PubMed ID: 33571672
[TBL] [Abstract][Full Text] [Related]
18. Xiexin Tang ameliorates dyslipidemia in high-fat diet-induced obese rats via elevating gut microbiota-derived short chain fatty acids production and adjusting energy metabolism.
Xiao S; Zhang Z; Chen M; Zou J; Jiang S; Qian D; Duan J
J Ethnopharmacol; 2019 Sep; 241():112032. PubMed ID: 31220598
[TBL] [Abstract][Full Text] [Related]
19. From gut microbiota dysfunction to obesity: could short-chain fatty acids stop this dangerous course?
Barrea L; Muscogiuri G; Annunziata G; Laudisio D; Pugliese G; Salzano C; Colao A; Savastano S
Hormones (Athens); 2019 Sep; 18(3):245-250. PubMed ID: 30840230
[TBL] [Abstract][Full Text] [Related]
20. The role of short-chain fatty acids in microbiota-gut-brain communication.
Dalile B; Van Oudenhove L; Vervliet B; Verbeke K
Nat Rev Gastroenterol Hepatol; 2019 Aug; 16(8):461-478. PubMed ID: 31123355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]